Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Diabetes save search
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Published: 2024-04-23 (Crawled : 05:00) - prnewswire.com
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 1.62%
H: 0.71%
C: 0.23%
cell for collaboration therapeutics diabetes agreement
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Published: 2024-04-09 (Crawled : 00:00) - biospace.com/
TNDM | $35.12 0.43% 0.43% 1M
|
Health Technology
|
| O: 0.3%
H: 4.7%
C: 3.68%
first care diabetes financial results
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
Published: 2024-04-04 (Crawled : 13:30) - globenewswire.com
FBLG | $11.55 4.05% 3.9% 69K
|
|
| O: -0.85%
H: 2.75%
C: 2.75%
treatment care mouse advanced diabetes usa
ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
ZVSA | $0.609 8.23% 7.6% 320K
|
|
| O: 7.38%
H: 2.6%
C: -3.23%
therapeutics diabetes potential
Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219
Published: 2024-04-01 (Crawled : 13:00) - globenewswire.com
BMEA | $10.76 -2.0% -2.04% 850K
|
Professional, Scientific, and T...
|
| O: 2.68%
H: 5.93%
C: -0.33%
bmf-219 first diabetes
Beyond Meat® Unveils New and Expanded Line of Beyond Crumbles, Now Certified by the American Heart Association’s Heart-Check Program and the American Diabetes Association’s Better Choices for Life Program
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
BYND 4 | $6.07 0.0% 1.8M
|
Consumer Non-Durables
|
| O: 1.69%
H: 2.97%
C: -1.78%
meat beyond life certified heart program diabetes
Parenteral Formula Market to Reach US$ 12.5 Billion by 2034 Amid Rising Prevalence of Cancer, AIDS, and Diabetes
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.12%
H: 0.88%
C: 0.0%
reach diabetes market
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
awiqli approval treatment diabetes insulin
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
Published: 2024-03-19 (Crawled : 13:30) - prnewswire.com
FBLG | $11.55 4.05% 3.9% 69K
|
|
| O: 0.11%
H: 38.0%
C: 21.22%
treatment diabetes
Digital Diabetes Management Market size is set to grow by USD 19.12 bn from 2024-2028, rising global burden of diabetes boost the market- Technavio
Published: 2024-03-13 (Crawled : 14:30) - prnewswire.com
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.31%
H: 0.4%
C: -1.08%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
PODD | $167.215 -0.03% -0.03% 650K
|
Health Technology
|
| O: 0.09%
H: 0.82%
C: -3.55%
DRIO | $1.51 4.14% 3.97% 40K
|
Health Technology
|
| O: -0.63%
H: 5.03%
C: 1.89%
management global set diabetes market
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
Published: 2024-03-12 (Crawled : 13:00) - globenewswire.com
HSCS | $0.1098 11.02% 9.93% 29M
|
n/a
|
| O: -0.41%
H: 2.42%
C: -2.58%
myovista publication technology diabetes
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
LXRX | $1.6 -0.62% -0.63% 1.8M
|
Health Technology
|
| O: 0.36%
H: 0.32%
C: -10.64%
disease kidney control treatment diabetes study
The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On
Published: 2024-03-11 (Crawled : 21:00) - prnewswire.com
DVA | News | $132.74 -0.87% 0.0% 470K
|
Health Services
|
| O: 0.01%
H: 2.86%
C: 2.48%
disease association diabetes
Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
LXRX | $1.6 -0.62% -0.63% 1.8M
|
Health Technology
|
| O: 6.91%
H: 21.55%
C: 21.12%
fda diabetes
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
Published: 2024-03-09 (Crawled : 12:20) - prnewswire.com
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
| Email alert
Add to watchlist
management international global system diabetes
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
Published: 2024-03-08 (Crawled : 15:00) - biospace.com/
SENS | $0.433 0.7% 0.0% 1.4M
|
Electronic Technology
|
| O: 1.51%
H: 6.65%
C: 4.18%
eversense conference approval international advanced diabetes study
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
Published: 2024-03-06 (Crawled : 11:00) - globenewswire.com
EMBC | $10.89 0.09% 0.09% 280K
|
n/a
|
| O: 1.26%
H: 0.81%
C: -1.25%
management symposium diabetes insulin
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
TNDM | $35.12 0.43% 0.43% 1M
|
Health Technology
|
| O: -0.39%
H: 2.61%
C: 0.26%
million care diabetes
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
LEXX | $2.18 -2.68% -2.75% 98K
|
Health Technology
|
| O: 4.33%
H: 15.34%
C: 7.99%
animal diabetes study
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Published: 2024-03-05 (Crawled : 12:30) - biospace.com/
PODD | $167.215 -0.03% -0.03% 650K
|
Health Technology
|
| O: 1.89%
H: 0.02%
C: -4.13%
omnipod first conference international trial advanced diabetes results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.